HONEST CO INC/THE (HNST)

US4383331067 - Common Stock

7.65  +0.4 (+5.52%)

Premarket: 7.51 -0.14 (-1.83%)

Fundamental Rating

3

Overall HNST gets a fundamental rating of 3 out of 10. We evaluated HNST against 36 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for HNST as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, HNST is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year HNST has reported negative net income.
In the past year HNST had a positive cash flow from operations.
HNST had negative earnings in each of the past 5 years.
In the past 5 years HNST reported 4 times negative operating cash flow.

1.2 Ratios

HNST's Return On Assets of -1.99% is on the low side compared to the rest of the industry. HNST is outperformed by 60.00% of its industry peers.
HNST has a Return On Equity of -3.12%. This is comparable to the rest of the industry: HNST outperforms 45.71% of its industry peers.
Industry RankSector Rank
ROA -1.99%
ROE -3.12%
ROIC N/A
ROA(3y)-16.98%
ROA(5y)-14.05%
ROE(3y)-27.42%
ROE(5y)-22.79%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HNST has a worse Gross Margin (36.91%) than 71.43% of its industry peers.
HNST's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HNST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.67%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

HNST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HNST has more shares outstanding
Compared to 1 year ago, HNST has an improved debt to assets ratio.

2.2 Solvency

HNST has an Altman-Z score of 5.26. This indicates that HNST is financially healthy and has little risk of bankruptcy at the moment.
HNST has a Altman-Z score of 5.26. This is in the better half of the industry: HNST outperforms 68.57% of its industry peers.
There is no outstanding debt for HNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.26
ROIC/WACCN/A
WACC9.05%

2.3 Liquidity

A Current Ratio of 2.89 indicates that HNST has no problem at all paying its short term obligations.
HNST has a better Current ratio (2.89) than 80.00% of its industry peers.
A Quick Ratio of 1.64 indicates that HNST should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.64, HNST is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.64

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.98% over the past year.
HNST shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.77%.
Measured over the past years, HNST shows a small growth in Revenue. The Revenue has been growing by 4.65% on average per year.
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.65%
Revenue growth 5YN/A
Sales Q2Q%15.17%

3.2 Future

HNST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.90% yearly.
Based on estimates for the next years, HNST will show a small growth in Revenue. The Revenue will grow by 5.98% on average per year.
EPS Next Y72.24%
EPS Next 2Y38.95%
EPS Next 3Y27.5%
EPS Next 5Y20.9%
Revenue Next Year8.98%
Revenue Next 2Y6.94%
Revenue Next 3Y6.4%
Revenue Next 5Y5.98%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

HNST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HNST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HNST is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.74
EV/EBITDA N/A

4.3 Compensation for Growth

HNST's earnings are expected to grow with 27.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.95%
EPS Next 3Y27.5%

0

5. Dividend

5.1 Amount

HNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HONEST CO INC/THE

NASDAQ:HNST (11/21/2024, 8:00:01 PM)

Premarket: 7.51 -0.14 (-1.83%)

7.65

+0.4 (+5.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap772.34M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.99%
ROE -3.12%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 36.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.89
Quick Ratio 1.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y72.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y